Bel Air Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$8.13M Sell
33,363
-1,256
-4% -$309K 0.25% 60
2021
Q1
$8.61M Buy
+34,619
New +$8.26M 0.27% 59
2013
Q3
$28.5M Buy
254,958
+4,283
+2% +$464K 4% 4
2013
Q2
$24.7M Buy
+250,675
New +$26M 3.62% 6

Other funds holding AMGN

Bel Air Investment Advisors's AMGN Position: Q2 2021 in Review

Bel Air Investment Advisors reduced its Amgen (AMGN) stake by 3.6% in Q2 2021, selling an estimated $309K and leaving 33,363 shares worth $8.13M. The position accounts for 0.25% of the portfolio, ranked #60.

Bel Air Investment Advisors first reported a position in AMGN in Q2 2013 and has held it in 4 quarters since. The position peaked at $28.5M in Q3 2013. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

  • Bel Air Investment Advisors held 33,363 shares of Amgen worth $8.13M as of Q2 2021.
  • Bel Air Investment Advisors sold 1,256 Amgen shares in Q2 2021, an estimated $309K.
  • Amgen made up 0.25% of Bel Air Investment Advisors's portfolio in Q2 2021, its #60 holding.
  • Bel Air Investment Advisors first reported a position in Amgen in Q2 2013 and has held it in 4 quarters since.
  • Bel Air Investment Advisors's Amgen position peaked at $28.5M in Q3 2013.
  • 2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on Bel Air Investment Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.